132 related articles for article (PubMed ID: 10874454)
1. Outpatient treatment of cancer patients with fever and neutropenia.
Karthaus M; Egerer G; Jürgens H
Antibiot Chemother (1971); 2000; 50():47-58. PubMed ID: 10874454
[No Abstract] [Full Text] [Related]
2. Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Cornely OA; Salzberger B; Bethe U; Seifert H; Fätkenheuer G; Diehl V; Schrappe M
Antibiot Chemother (1971); 2000; 50():37-46. PubMed ID: 10874453
[No Abstract] [Full Text] [Related]
3. Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
Karthaus M; Egerer G; Kullmann KH; Ritter J; Jürgens H
Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):501-4. PubMed ID: 9764553
[TBL] [Abstract][Full Text] [Related]
4. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Petrilli AS; Dantas LS; Campos MC; Tanaka C; Ginani VC; Seber A
Med Pediatr Oncol; 2000 Feb; 34(2):87-91. PubMed ID: 10657866
[TBL] [Abstract][Full Text] [Related]
5. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
6. Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
Zubizarreta P; Paganini H
Med Pediatr Oncol; 2002 Apr; 38(4):292. PubMed ID: 11920803
[No Abstract] [Full Text] [Related]
7. Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children.
Charnas R; Lüthi AR; Ruch W
Pediatr Infect Dis J; 1997 Apr; 16(4):346-53. PubMed ID: 9109134
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.
Karthaus M; Wolf HH; Kämpfe D; Egerer G; Ritter J; Peters G; Südhoff T; Franke A; Heil G; Kullmann KH; Jürgens H
Chemotherapy; 1998; 44(5):343-54. PubMed ID: 9732151
[TBL] [Abstract][Full Text] [Related]
9. Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia.
Karthaus M; Südhoff T; Egerer G; Fenchel K; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
Antibiot Chemother (1971); 2000; 50():26-36. PubMed ID: 10874452
[No Abstract] [Full Text] [Related]
10. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: comparison of outpatient and inpatient care.
Egerer G; Goldschmidt H; Müller I; Karthaus M; Günther H; Ho AD
Chemotherapy; 2001; 47(3):219-25. PubMed ID: 11306792
[TBL] [Abstract][Full Text] [Related]
12. Outpatient antimicrobial protocol for febrile neutropenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents.
Sahu S; Bapna A; Pai SK; Nair CN; Kurkure PA; Advani SH
Pediatr Hematol Oncol; 1997; 14(3):205-11. PubMed ID: 9185205
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
14. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
Minotti V; Gentile G; Bucaneve G; Iori AP; Micozzi A; Cavicchi F; Barbabietola G; Landonio G; Menichetti F; Martino P; Del Favero A
Support Care Cancer; 1999 May; 7(3):134-9. PubMed ID: 10335931
[TBL] [Abstract][Full Text] [Related]
15. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.
Mustafa MM; Aquino VM; Pappo A; Tkaczewski I; Buchanan GR
J Pediatr; 1996 Jun; 128(6):847-9. PubMed ID: 8648546
[TBL] [Abstract][Full Text] [Related]
17. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
18. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
19. A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
Cornely OA; Bethe U; Seifert H; Breuer K; Schütt-Gerowitt H; Salzberger B; Schrappe M; Fätkenheuer G
Ann Hematol; 2002 Jan; 81(1):37-43. PubMed ID: 11807634
[TBL] [Abstract][Full Text] [Related]
20. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP
Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
